[Spectomycin B1 induces VEGFR2 de-SUMO modification to inhibit angiogenesis in nasopharyngeal carcinoma].

Ren, Q; Zhang, C Y; Ma, X F; Cheng, R Z; Bian, X Y; Xiao, X L; Liu, X Z; Zhou, H F

Ren, Q; Zhang, C Y; Ma, X F; Cheng, R Z; Bian, X Y; Xiao, X L; Liu, X Z; Zhou, H F.

Afiliação

Ren Q; Department of Otorhinolaryngologyï¼the Fifth Central Hospital of Tianjinï¼Tianjinï¼300450ï¼China.
Zhang CY; Department of Pharmacyï¼Tianjin Binhai New Area Hospital of Traditional Chinese Medicine.
Ma XF; Central Laboratoryï¼the Fifth Central Hospital of Tianjin.
Cheng RZ; Department of Pharmacyï¼Tianjin Binhai New Area Hospital of Traditional Chinese Medicine.
Bian XY; Central Laboratoryï¼the Fifth Central Hospital of Tianjin.
Xiao XL; Central Laboratoryï¼the Fifth Central Hospital of Tianjin.
Liu XZ; Central Laboratoryï¼the Fifth Central Hospital of Tianjin.
Zhou HF; Department of Otorhinolaryngologyï¼Tianjin Medical University General Hospital.

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi ; 33(12): 1181-1184, 2019 Dec.

Article em Zh | MEDLINE | ID: mdl-31914270

Assuntos

Carcinoma Nasofaríngeo; Neoplasias Nasofaríngeas; Espectinomicina; Fator A de Crescimento do Endotélio Vascular/metabolismo; Animais; Apoptose; Camundongos; Neovascularização Patológica

Palavras-chave

nasopharyngeal neoplasms; small ubiquitin-related modified protein; spectomycin B1; vascular endothelial growth factor receptor 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Espectinomicina / Fator A de Crescimento do Endotélio Vascular / Carcinoma Nasofaríngeo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: Zh Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google